Skip to main content

Advertisement

Figure 2 | Journal of Biomedical Science

Figure 2

From: Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase

Figure 2

Effect of SeMet conversion by MT-AV on PC-3 cell viability. Cells treated with varying concentrations of SeMet were compared their corresponding control groups treated with 0 nM concentrations on the same day, and significant differences are denoted by # (p < 0.05), * (p < 0.01), and ** (p < 0.001). Data presented as mean ± SE (n = 3).

Back to article page